Date: 2011-02-23
Type of information: Private placement
Company: 4SC (Germany)
Investors:
Amount:
Funding type: capital increase
Planned used:
Others: 4SC AG has decided to make partial use of the authorised capital to increase the Company's share capital from 38,502,739 shares to up to 42,353,011 shares by issuing up to 3,850,272 new, no-par value bearershares, each with a notional interest of € 1.00 in the share capital. The new shares will be offered to institutional investors as part of an accelerated book-building process, excluding the subscription rights of the existing shareholders.
Therapeutic area: Autoimmune diseases - Cancer - Oncology
